Salim Syed
Stock Analyst at Mizuho Securities
(1.57)
# 3,580
Out of 5,118 analysts
1122
Total ratings
41.6%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Salim Syed
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Reiterated: Buy | $47 | $18.28 | +157.11% | 7 | Oct 20, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | $163 | $63.89 | +155.13% | 25 | Oct 5, 2026 | |
| ASMB Assembly Biosciences | Reiterated: Buy | $45 → $53 | $20.42 | +159.55% | 41 | Aug 31, 2026 | |
| ATRA Atara Biotherapeutics | Reiterated: Buy | $18 | $7.87 | +128.72% | 82 | Aug 31, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $96 → $110 | $74.29 | +48.07% | 108 | Aug 31, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $170 | $166.89 | +1.86% | 112 | Aug 31, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $25 | $7.27 | +243.88% | 10 | Aug 31, 2026 | |
| AMGN Amgen | Reiterated: Hold | $303 → $352 | $460.42 | -23.55% | 172 | Aug 17, 2026 | |
| ELVN Enliven Therapeutics | Reiterated: Buy | $62 → $73 | $49.43 | +47.68% | 18 | Aug 17, 2026 | |
| IOVA Iovance Biotherapeutics | Reiterated: Buy | $10 → $11 | $8.04 | +36.82% | 6 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.68 | +376.19% | 4 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.73 | +593.64% | 43 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $221 → $241 | $248.35 | -2.96% | 133 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 → $137 | $119.65 | +14.50% | 8 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $23 | $3.37 | +583.51% | 81 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $118 | $53.69 | +119.78% | 146 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $97 | $34.19 | +183.71% | 4 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.28 | +681.25% | 6 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $43 | $9.54 | +350.73% | 8 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.84 | +335.97% | 2 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $50.07 | n/a | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $146.73 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $35.75 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $29.39 | n/a | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $4.32 | n/a | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.77 | n/a | 73 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $11.69 | n/a | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $56.03 | n/a | 1 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $22.96 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.1 | $7.22 | n/a | 1 | Jul 2, 2019 |
Arcus Biosciences
Oct 20, 2026
Reiterated: Buy
Price Target: $47
Current: $18.28
Upside: +157.11%
Vaxcyte
Oct 5, 2026
Reiterated: Buy
Price Target: $163
Current: $63.89
Upside: +155.13%
Assembly Biosciences
Aug 31, 2026
Reiterated: Buy
Price Target: $45 → $53
Current: $20.42
Upside: +159.55%
Atara Biotherapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $18
Current: $7.87
Upside: +128.72%
BridgeBio Pharma
Aug 31, 2026
Reiterated: Buy
Price Target: $96 → $110
Current: $74.29
Upside: +48.07%
Gilead Sciences
Aug 31, 2026
Reiterated: Buy
Price Target: $170
Current: $166.89
Upside: +1.86%
Kura Oncology
Aug 31, 2026
Reiterated: Buy
Price Target: $25
Current: $7.27
Upside: +243.88%
Amgen
Aug 17, 2026
Reiterated: Hold
Price Target: $303 → $352
Current: $460.42
Upside: -23.55%
Enliven Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $62 → $73
Current: $49.43
Upside: +47.68%
Iovance Biotherapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $8.04
Upside: +36.82%
Aug 17, 2026
Reiterated: Buy
Price Target: $8
Current: $1.68
Upside: +376.19%
Aug 17, 2026
Reiterated: Buy
Price Target: $12
Current: $1.73
Upside: +593.64%
Aug 3, 2026
Reiterated: Buy
Price Target: $221 → $241
Current: $248.35
Upside: -2.96%
Aug 3, 2026
Reiterated: Buy
Price Target: $121 → $137
Current: $119.65
Upside: +14.50%
Aug 3, 2026
Reiterated: Buy
Price Target: $27 → $23
Current: $3.37
Upside: +583.51%
Jun 23, 2026
Reiterated: Buy
Price Target: $100 → $118
Current: $53.69
Upside: +119.78%
Jun 23, 2026
Reiterated: Buy
Price Target: $97
Current: $34.19
Upside: +183.71%
Jun 10, 2026
Reiterated: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
Mar 30, 2026
Reiterated: Buy
Price Target: $45 → $43
Current: $9.54
Upside: +350.73%
Nov 14, 2025
Reiterated: Buy
Price Target: $8
Current: $1.84
Upside: +335.97%
May 20, 2025
Reiterated: Buy
Price Target: $85
Current: $50.07
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $146.73
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $35.75
Upside: n/a
May 28, 2024
Reiterated: Buy
Price Target: $53
Current: $29.39
Upside: n/a
Mar 25, 2024
Reiterated: Buy
Price Target: $25
Current: $4.32
Upside: n/a
Jun 16, 2023
Rated: Hold
Price Target: n/a
Current: $0.77
Upside: n/a
Mar 6, 2023
Reiterated: Buy
Price Target: $21
Current: $11.69
Upside: n/a
Nov 3, 2022
Reiterated: Buy
Price Target: $23
Current: $56.03
Upside: n/a
Aug 4, 2022
Reiterated: Buy
Price Target: $25
Current: $22.96
Upside: n/a
Jul 2, 2019
Reiterated: Buy
Price Target: $7.1
Current: $7.22
Upside: n/a